External Advisory Board

The role of the CGH External Advisory Board is to help develop the Center for Global Health's strategic vision and to provide counsel and support on both conceptual and programmatic levels. In order to assure the highest standards in education, research, and clinical activities, Advisory Board members serve as external evaluators of CGH. Each member brings unique experience, wisdom, and expertise to the CGH and to the University of Chicago community. 

Anju Ahuja, MBA


 Anju Ahuja is Vice President of Market Development and Product Management at CableLabs, innovation lab for the global cable industry. She is responsible for identifying billion+ dollar new target markets and products for the cable industry. Anju leads a team of talented product managers in collaborating with distinguished technologists and engineers. Their charge is to integrate emerging technologies like AR, VR, MR, AI and more into media and communications, transforming end user experiences and revolutionizing content, while also unleashing massive monetization opportunities. Prior to joining CableLabs in 2015, Anju spent a decade at boutique media tech advisory firm Psyche Manufactory working directly with media tech startup boards and their management teams on product and strategy. Previously, she was a venture capitalist with a large family of funds at First Analysis and was also a founding partner of a spin out technology venture capital fund. Early in her career, Anju worked in private equity at Bank of America’s Principal Investing Group, where her “baptism by fire” was the successful turnaround of an underperforming highly leveraged publicly traded company and the repositioning and sales of other underperforming portfolio companies at attractive multiples. Her roots in product and business strategy were shaped at The Boston Consulting Group, where she was an associate. Anju has an Executive MBA from Kellogg School of Management at Northwestern University. She received her BA in Economics from The University of Chicago and credits this for her deep reverence for market forces and innovation strategy. 

Michele Barry, MD, FACP 

Michele Barry, MD, FACP is the Senior Associate Dean for Global Health and Director of the Center for Innovation in Global Health in the Stanford School of Medicine. As Director of the Yale/Stanford Johnson and Johnson Global Health Scholar Award program, she has sent over 1000 physicians overseas to underserved areas to help strengthen health infrastructure in low resource settings. As a past President of the American Society of Tropical Medicine and Hygiene, she led an educational initiative in tropical medicine and travelers health which culminated in diploma courses in tropical medicine both in the U.S. and overseas, as well as a U.S. certification exam. Dr. Barry is an elected member of the Institute of Medicine and National Academy of Science and is past-Chair of the Interest Group on Global Health, Infectious Diseases and Microbiology at the IOM. She has been listed in Best Doctors in America and serves on the Board of Directors of the Bill and Melinda Gates funded Consortium of Universities involved in Global Health (CUGH) and the Foundation of the Advancement of International Education (FAIMER). Areas of scholarly interest include global health workforce, clinical tropical medicine, emerging infectious diseases, problems of underserved populations and globalization's impact upon health in the developing world.

Aaron Bernstein, MD, MPH 

Aaron Bernstein is the Associate Director of the Center for Health and the Global Environment and a pediatric hospitalist at Boston Children’s Hospital. Dr. Bernstein’s work examines the human health effects of global environmental changes, such as climate change and the loss of biodiversity, with the aim of promoting a deeper understanding of these subjects among students, educators, policy makers, and the public. Having attended Stanford University for college, he received graduate degrees in medicine and public health from the University of Chicago and Harvard University, respectively. He is a recipient of Stanford University’s Firestone Medal for Research and a Harvard University Zuckerman Fellowship. With Nobel Laureate Eric Chivian, he co-authored and co-edited the Oxford University Press book Sustaining Life, which received the distinction of best biology book of 2008 from the Library Journal along with Bert Holldobler and E.O. Wilson’s The Superorganism

Haile Debas, MD

Haile T. Debas, MD is recognized internationally for his contributions to academic medicine and is widely consulted on issues associated with global health. At the University of California, San Francisco, he served as the Founding Executive Director of UCSF Global Health Sciences (2003-2010), Dean (Medicine) (1993-2003), Vice Chancellor (Medical Affairs) for six years, and Chancellor for one year. A gastrointestinal surgeon by training, Dr. Debas is also the Maurice Galante Distinguished Professor of Surgery, Emeritus and chaired the UCSF Department of Surgery from 1987 to 2003. He is also the Founding Director of the University of California-wide Global Health Institute. He was instrumental in the creation of the Consortium of Universities for Global Health and served as the Founding Chair of its Board of Directors (2009-2012). A native of Eritrea, he received his M.D. from McGill University and completed his surgical training at the University of British Columbia (UBC), and post-doctoral fellowship at UCLA. He previously held faculty positions at UBC, UCLA, and the University of Washington. Under Dr. Debas’s stewardship, the UCSF School of Medicine became a national model for medical education, an achievement for which he was recognized with the 2004 Abraham Flexner Award for Distinguished Service to Medical Education of the AAMC. His prescient grasp of the implications of fundamental changes in science led him to create several interdisciplinary research centers that have been instrumental in reorganizing the scientific community at UCSF. He played a key role in developing UCSF’s new campus at Mission Bay. He has held leadership positions with numerous membership organizations and professional associations including serving as president of the American Surgical Association and Chair of the Council of Deans of the AAMC. He served for two terms as a member of the Committee on Science, Engineering, and Public Policy of the National Academy of Sciences, and was a member of the United Nations’ Commission on HIV/AIDS and Governance in Africa. He is a member of the Institute of Medicine, and served as chair of the Membership Committee. Dr. Debas is a fellow of the American Academy of Arts and Sciences. He currently is a member of the Board of Regents of the Uniformed Services University of the Health Sciences, a member of the Advisory Committee to the Director of the National Institutes of Health, and a member of the Board of Trustees of the Aga Khan University. In 2012, he was awarded the UCSF Medal for his academic and leadership contributions to the University.

Pierce Gardner, MD

Pierce Gardner, MD is a consultant for International Clinical Scholars Program at the Fogarty International Center, National Institutes of Health, and Professor of Medicine and Public Health at the medical school at Stony Brook University, New York. For nine years Dr. Gardner served as the liaison representative of the American College of Physicians to the Advisory Committee on Immunization Practices at the Centers for Disease Control (CDC). He also served in the Epidemic Intelligence Service at CDC where he was the Chief of the Central Nervous System Viral Surveillance Unit. Dr Gardner has done extensive international work and has been a consultant for the World Health Organization and CDC. Dr. Gardner has published more than 125 articles, reviews, and books, primarily dealing with immunization issues and health issues of international travel. He has a long interest in adult immunization, and has served as editor of the most recent edition of the "Guide for Adult Immunization" published by the American College of Physicians and Infectious Diseases Society of America. Dr. Gardner graduated from Harvard Medical School and trained in Internal Medicine at the University of Washington and at Case Western Reserve. Dr. Gardner did his fellowship training in Infectious Diseases at the Massachusetts General Hospital. His major academic appointments have been at Harvard Medical School, the University of Chicago, and Stony Brook University.


Doug Given, MD, PhD, MBA

Dr. Given has served as Chairman, Chief Executive Officer and President of Vivaldi Biosciences Inc. since its founding. He also is Chairman of the Supervisory Board of Vivaldi Biosciences AG. Dr. Given is a Managing Partner of G5 Partners and is an advisor to Bay City Capital, where he was an Investment Partner for ten years. Previously, he was Chief Executive Officer and a director of NeoRx, and Corporate Senior Vice President and Chief Technology Officer of Mallinckrodt. Prior to joining Mallinckrodt, Dr. Given served as Chief Executive Officer and a director of Progenitor and Mercator Genetics. Previously, he held positions as Vice President at Schering-Plough Research Institute, Vice President at Monsanto / GD Searle Research Laboratories, and Medical Advisor at Lilly Research Laboratories. Dr. Given is Chairman of Arrowhead Research Corp. and Chairman of Medical eXellence, Inc. He also has served on the boards of directors of eight private and eight public biomedical companies. Dr. Given is Chairman of the Visiting Committee to the Medical Center, Division of Biological Sciences and the Pritzker School of Medicine at the University of Chicago, a member of the Johns Hopkins Bloomberg School of Public Health Advisory Board, and a member of the International Advisory Committee, Harvard School of Public Health. Dr. Given received a BS degree in Physical Sciences from Colorado State University. He holds an MD with honors and a PhD from the University of Chicago, and an MBA from the Wharton School, University of Pennsylvania. He was a fellow in Internal Medicine and Infectious Diseases at Harvard Medical School and Massachusetts General Hospital.

Richard Joseph, PhD

Richard Joseph previously taught at Emory University, Dartmouth College, the University of California at Los Angeles, the University of Ibadan (Nigeria), and the University of Khartoum (Sudan). He has held research fellowships at Harvard University, Boston University, the Massachusetts Institute of Technology, the Institute of Development Studies (Sussex, UK), Chr. Michelsen Institute (Norway), and the Ecole des Hautes Etudes en Sciences Sociales (France). Joseph has devoted his scholarly career to the study of politics and governance in Africa with a special focus on democratic transitions, state building and state collapse, and conflict resolution. He directed the African Governance Program at the Carter Center (1988-1994) and coordinated elections missions in Zambia (1991), Ghana (1992), and peace initiatives in Liberia (1991-1994). He has been a longtime member of the Council of Foreign Relations. Joseph is the recipient of numerous fellowships and awards including a Rhodes Scholarship, a Kent Fellowship, and a Guggenheim Fellowship. In 2002-03, he held visiting fellowships at the U.S. Institute of Peace and the National Endowment for Democracy. He was a Fulbright Scholar in France and a Fulbright Professor in Nigeria.

William Martin, MD

William J. Martin II comes to the College of Public Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH), where he served as associate director for disease prevention and health. Martin has substantial experience in both academia and in governmental scientific administration. One of his principal activities at NIH was the development and implementation of research and training programs across the U.S. government to reduce the global burden of disease among women and children from household air pollution in developing countries, which causes nearly four million deaths each year. Prior to serving at the NICHD , he served as associate director of NIH's National Institute of Environmental Health Sciences, and as its director of the Office of Translational Research, where he led the Head-Off Environmental Asthma in Louisiana (HEAL) study of asthma outcomes in children in post-Katrina New Orleans. As a physician-scientist in lung injury and repair, he has authored more than 160 research and clinical papers and was an NIH-funded researcher for 24 years. His professional service includes being president of the American Thoracic Society, president of the American Lung Association of Indiana, a member of the Advisory Council for the National Heart, Lung and Blood Institute, and a health policy fellow for the U.S. Senate Labor and Human Resources Committee. In addition, his honors and recognitions include the Sagamore of the Wabash Award from the governor of Indiana; NIH's Director's Award; and the President's Volunteer Service Award for his work with Project Hope during Hurricane Katrina relief. Further, he has served three times in Haiti as a volunteer physician since the earthquake there in 2010. He is also included on the America's Best Doctors listing. Martin began his academic career as an assistant professor at the Mayo Clinic in Rochester, Minn., providing clinical care as well as starting his research laboratory. He then served as professor of medicine and director of the Division of Pulmonary, Allergy, Critical Care and Occupational Medicine at Indiana University School of Medicine, and ultimately became that School of Medicine's executive associate dean for clinical affairs and president of the faculty practice plan. He then served as dean of the College of Medicine at the University of Cincinnati prior to joining the NIH in 2006.

Joanna Rubinstein, PhD

Dr. Joanna Rubinstein is the Assistant Director of the Earth Institute for International Programs, and Special Advisor to Professor Jeffrey Sachs. She is trained as a DDS and a scientist with a Ph.D. in cell and molecular biology. She uses her 15 years of experience as a practicing scientist and senior administrator in Europe to coordinate complex projects across the Earth Institute. On the international front, she was responsible for the science and health initiatives of the UN Millennium Project and helped to develop collaborations with foreign academic institutions, research-funding organizations and the private sector. Joanna leads several strategic initiatives within the University and with external partners, including the Malaria Quick Impact Initiative, scaling up of Neglected Tropical Disease Control, Digital Health, Early Childhood Development, the Drylands Initiative, and national advisory programs to scale up health systems to attain the Millennium Development Goals. Before coming to the Earth Institute in 2005, Joanna was the Senior Associate Dean for Institutional and Global Initiatives at the Columbia University Medical Center. Prior to that, Joanna was at the Karolinska Institute in Stockholm, Sweden, where she was director for research and postgraduate education from 1999 to 2002. She also served as Sweden's representative to a European Commission committee and was a director at Sweden's Medical Research Council (1997–99).

Peter Small, MD

Dr. Small is Founding Director of the Stony Brook University Global Health Institute (GHI). For nearly a decade, Peter Small served as the Team Leader for Tuberculosis at the Bill and Melinda Gates Foundation. In that capacity he was responsible for developing the foundation's tuberculosis strategy, building the programs core partnerships, overseeing development of new TB diagnostics, drugs and vaccines, hiring and managing the team and serving as the foundation's voice for tuberculosis. In 2011 he relocated with his family to New Delhi for two years where designed and implemented the foundation's TB program in India which partners with the Indian Government, World Bank, USAID, other foundations, and private enterprises to integrate a variety of delivery innovations. Dr. Small is a global expert in several aspects of TB treatment, epidemiology, biology and control. He has published more than 150 articles and chapters including studies in the New England Journal of Medicine, Lancet, Science, and Nature that helped to shape the public health response to the resurgence of tuberculosis in the 1990's. Much of this involved collaborative efforts with basic scientists, public health officials and clinicians to use of molecular epidemiologic techniques to answer pragmatic questions about the control of tuberculosis. This work included population based field research projects in San Francisco, Latin America, Africa, Asia and Europe. In 2002, he was awarded the Princess Chichibu Global Tuberculosis Award for his contributions to global tuberculosis control. In addition to his work at the Gates Foundation, until December 2007, he was an Affiliate Professor at the Institute of Systems Biology in Seattle where his lab focused on the nature and consequences of genetic variability within the species M. tuberculosis as it pertains to fundamental questions about mycobacterial ecology and evolution. He served as a member of the Institute of Medicine's committee addressing the elimination of tuberculosis in the United States, the Board of Directors of several public private partnerships, the Technical Advisory Group of the Global Fund, the WHO Stop TB Coordinating Board and is a Fellow in the American Association of Microbiology.